跳至主要内容
临床试验/NCT07216040
NCT07216040尚未招募不适用

Harnessing Optimism and Perseverance in the Face of Long COVID~Español (HOPE-LC~Español)

Icahn School of Medicine at Mount Sinai2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2026年5月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
25
试验地点
2
主要终点
Recruitment rate

研究概览

简要总结

The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.

详细描述

The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, developed by Drs. Eric Watson (PI) and Amelia Hicks (co-I), is a 12-week online group therapy program tailored specifically to living with Long COVID as a chronic condition. HOPE-LC provides community and hope; fostering resilience, adjustment, and critical coping strategies in the face of this debilitating chronic condition. Since its inception in 2024, the HOPE-LC groups have engaged 20 patients, emphasizing the need for chronic Long COVID therapeutic interventions.

Through HOPE-LC-Espanol the researchers will translate and adapt the HOPE-LC program into Spanish and expand HOPE-LC's reach to underserved Spanish-speaking communities in Queens and NYC. The aims are: (1) To translate and culturally adapt the HOPE-LC program for Spanish-speaking patients in collaboration with the Advisory Board of Spanish-speaking clinicians, Long COVID experts, and individuals with Long COVID lived experience; (2) In collaboration with the partners at H+H/Elmhurst and H+H/Queens, to conduct targeted recruitment to ensure the researchers are engaging specifically with local Hispanic/Latinx communities in Queens; and (3) To complete the HOPE-LC~Español program for 25 Spanish-speaking individuals experiencing Long COVID within the local Queens community. The researchers will evaluate program feasibility and treatment success to inform future scalability and sustainability as a clinical program.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

Single arm

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older.
  • Speaks and understands Spanish at a level that allows active participation in group-based study procedures.
  • Self-reported history of Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms affecting daily functioning or a medical professional has diagnosed you with a Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms.
  • Ability to participate in group sessions either in-person or via telehealth (Zoom).
  • Willingness and capacity to provide informed consent.

排除标准

  • Presence of severe psychiatric conditions that would preclude participation in group therapy (e.g., active psychosis, suicidal intent requiring immediate intervention).
  • Inability to communicate in Spanish sufficiently to engage meaningfully in group sessions.
  • Cognitive or physical impairments prevent participation in group sessions or completion of surveys, without available accommodations.
  • Concurrent participation in another conflicting interventional trial targeting Long COVID symptoms.

研究组 & 干预措施

Patients Living with Chronic Long-COVID

Experimental

Spanish-speaking patients in the HOPE-LC program.

干预措施: HOPE-LC~Espanol (Behavioral)

结局指标

主要结局

Recruitment rate

时间窗: Throughout the study period, 12 weeks

Number of eligible participants screened and enrolled by referral source

Retention rate

时间窗: Throughout the study period, 12 weeks

Number of participants completing the intervention (defined as attending at least 8 of 12 sessions)

Number of sessions participants attended

时间窗: Throughout the study period, 12 weeks

Feasibility measured via participant attendance

Number of completed surveys

时间窗: Throughout the study period, 12 weeks

Feasibility measured via number of surveys completed from participant follow-up and study procedures.

Patient Satisfaction

时间窗: Post-treatment (Week 12)

Post-treatment survey assessing participant satisfaction with HOPE-LC\~Español. Items are on a 5-point Likert Scale evaluated agreement to statements about their experience in the program (e.g., feeling heard, learning practical strategies, and willingness to recommend the program). The total score range is 5 - 40, with higher ratings indicating greater satisfaction.

次要结局

  • DePaul Symptom Questionnaire(Baseline; 6 weeks, 12 weeks)
  • Brief Illness Perception Questionnaire (BIPQ)(Baseline; 6 weeks, 12 weeks)
  • Valued Based Living Questionnaire (VLQ)(Baseline; 6 weeks, 12 weeks)
  • Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm)(Baseline; 6 weeks, 12 weeks)
  • Patient Health Questionnaire-8 Item (PHQ-8)(Baseline; 6 weeks, 12 weeks)
  • Generalized Anxiety Disorder-7 Item (GAD-7)(Baseline; 6 weeks, 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Watson

Assistant Professor

Icahn School of Medicine at Mount Sinai

研究点 (2)

Loading locations...

相似试验